@FierceBiotech: Novartis grabs FDA's coveted 'breakthrough' status for lung cancer drug. More | Follow @FierceBiotech
@JohnCFierce: Tillman Gerngross (Adimab) has a new biotech startup.Avitide. A service company: More | Follow @JohnCFierce
@RyanMFierce: Merck hit with delay on FDA review of top drug prospect. Article | Follow @RyanMFierce
> Investigators find that rapid antiviral response to new cases of HIV infection could deliver "functional cures." Report
> A Senate bill could boost the FDA budget despite the impact of sequestration. Item
> Venture-funded biotech Lithera has mounted a 500-patient Phase IIb study for an injected treatment to reduce body fat. Article
> OvaScience, a biotech focused on women's reproductive medicine, plans to raise $35 million in a financing. More
Pharma News
@FiercePharma: Claris injectables unit seen as M&A target for Teva, Pfizer, now that Mylan has Agila Specialties. More | Follow @FiercePharma
@EricPFierce: FDA acts quickly to assess potential cancer risks of Type 2 diabetes drugs, Merck's Januvia, Bemis' Byetta. Story | Follow @EricPFierce
> Vivus hopes weight-loss app will fatten up Qsymia sales. More
> Pfizer's Read gets small raise in tough year. Article
> Generic drugmakers concerned over FDA turmoil. More
@FierceMedDev: Intuitive slides as doc group slams robotic surgery 'hype.' More | Follow @FierceMedDev
@MarkHFierce: A brain Dx would measure tumor DNA to gauge how advanced breast cancer patients are responding to drugs. Article | Follow @MarkHFierce
@DamianFierce: Illumina has to fork over $96 million in a patent suit over sequencing. Story | Follow @DamianFierce
> Sorin banks on up to 30% profit growth in 2013. More
> Study: Johns Hopkins brain stent saves patients from blindness. Article
And Finally… Researchers poked fresh holes in the case for a causal link between hormone replacement therapy and breast cancer. Article